IN2012DN02419A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02419A
IN2012DN02419A IN2419DEN2012A IN2012DN02419A IN 2012DN02419 A IN2012DN02419 A IN 2012DN02419A IN 2419DEN2012 A IN2419DEN2012 A IN 2419DEN2012A IN 2012DN02419 A IN2012DN02419 A IN 2012DN02419A
Authority
IN
India
Prior art keywords
coating
dilatable
medical products
coated
transport
Prior art date
Application number
Inventor
Michael Hoffmann
Erika Hoffmann
Roland Horres
Original Assignee
Hemoteq Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemoteq Ag filed Critical Hemoteq Ag
Publication of IN2012DN02419A publication Critical patent/IN2012DN02419A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention is related to dilatable medical products having short-term contact with the organism, as e.g. balloon catheters coated with at least one layer of at least one antiproliferative, immunosuppressive, anti-angiogenic, anti-inflammatory, fungicidal and/or anti-thrombotic agent and a transport mediator or a mixture of transport mediators, methods for coating of these coated dilatable medical products and the use of compositions for this coating.
IN2419DEN2012 2009-10-16 2010-10-16 IN2012DN02419A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009050295 2009-10-16
PCT/DE2010/001220 WO2011044889A1 (en) 2009-10-16 2010-10-16 Use of compositions to coat catheter balloons and coated catheter balloons

Publications (1)

Publication Number Publication Date
IN2012DN02419A true IN2012DN02419A (en) 2015-08-21

Family

ID=43719512

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2419DEN2012 IN2012DN02419A (en) 2009-10-16 2010-10-16

Country Status (14)

Country Link
US (1) US20120316496A1 (en)
EP (1) EP2461842A1 (en)
JP (1) JP2013507204A (en)
KR (1) KR20120098624A (en)
CN (1) CN102573946A (en)
AU (1) AU2010306251A1 (en)
BR (1) BR112012006925A2 (en)
CA (1) CA2777254A1 (en)
DE (1) DE112010004061A5 (en)
IL (1) IL219165A0 (en)
IN (1) IN2012DN02419A (en)
MX (1) MX2012004410A (en)
RU (1) RU2012120089A (en)
WO (1) WO2011044889A1 (en)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9724729B2 (en) * 2010-12-22 2017-08-08 Abbott Laboratories Method of modifying a coating on a medical device
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (en) 2011-11-23 2021-12-14 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
US20130303983A1 (en) * 2012-05-09 2013-11-14 Cook Medical Technologies Llc Coated medical devices including a water-insoluble therapeutic agent
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10898700B2 (en) 2012-10-26 2021-01-26 Urotronic, Inc. Balloon catheters for body lumens
US10881839B2 (en) 2012-10-26 2021-01-05 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11504450B2 (en) 2012-10-26 2022-11-22 Urotronic, Inc. Drug-coated balloon catheters for body lumens
WO2020172560A1 (en) 2019-02-22 2020-08-27 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11938287B2 (en) 2012-10-26 2024-03-26 Urotronic, Inc. Drug-coated balloon catheters for body lumens
JP2015536709A (en) * 2012-10-26 2015-12-24 ウロトロニック・インコーポレイテッドＵｒｏｔｒｏｎｉｃ， Ｉｎｃ． Drug-coated balloon catheter for nonvascular stenosis
US10806830B2 (en) 2012-10-26 2020-10-20 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
JP6442135B2 (en) * 2013-04-01 2018-12-19 テルモ株式会社 Balloon coating method
CN103272539B (en) * 2013-05-07 2015-08-12 李光武 Drying under reduced pressure prepares the method for aeroge
CN103316417A (en) * 2013-06-08 2013-09-25 周玉杰 Cone-shaped balloon dilatation catheter
JP6163032B2 (en) * 2013-07-02 2017-07-12 テルモ株式会社 Balloon coating method and balloon coating apparatus
CN106163602B (en) * 2014-04-01 2019-11-01 泰尔茂株式会社 Sacculus coating method, coating coating control method and sacculus applying device
MX2016014281A (en) 2014-05-22 2017-02-22 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies.
US9492594B2 (en) * 2014-07-18 2016-11-15 M.A. Med Alliance SA Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs
US11406742B2 (en) 2014-07-18 2022-08-09 M.A. Med Alliance SA Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs
US11904072B2 (en) 2015-04-24 2024-02-20 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2018050916A1 (en) * 2016-09-19 2018-03-22 Biotronik Ag Polymer-free drug eluting vascular stents
CN106621003A (en) * 2016-11-10 2017-05-10 乐普（北京）医疗器械股份有限公司 A drug balloon catheter and its preparation method and application
CN107497034A (en) * 2017-09-26 2017-12-22 上海市第人民医院 A kind of band coating screw thread catheter
CN112535793B (en) * 2020-11-19 2021-10-08 融冲(深圳)生物医疗科技有限责任公司 Preparation method and application of drug-coated balloon catheter
CN112587734A (en) * 2020-12-15 2021-04-02 济南金泉生物科技有限公司 Multifunctional coating based on bionic dopamine and preparation method and application thereof
WO2022154055A1 (en) * 2021-01-13 2022-07-21 地方独立行政法人神奈川県立産業技術総合研究所 Polyglycerol, complex gel composition containing said polyglycerol, drug delivery micro-needle including said complex gel composition, and methods for producing same
EP4323047A4 (en) * 2021-04-12 2025-01-08 Orbusneich Medical (Shenzhen) Co., Ltd. Expandable balloon catheter
EP4491203A4 (en) * 2022-03-22 2025-04-16 Lepu Medical Technology (Beijing) Co., Ltd. Drug coating, drug balloon, manufacturing method for drug balloon and use thereof
WO2023220637A2 (en) * 2022-05-11 2023-11-16 J.D. Franco & Co., Llc Drug coated devices and methods for the treatment of eye disease
CN115536920B (en) * 2022-08-26 2023-05-26 武汉理工大学 Chitosan derivative-based wound repair hydrogel and preparation method and application thereof
CN115518191B (en) * 2022-09-16 2023-07-28 浙江隆泰医疗科技有限公司 Preparation method of medical dressing capable of promoting wound to quickly stop bleeding

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186745A (en) 1976-07-30 1980-02-05 Kauzlarich James J Porous catheters
DE69023362T2 (en) 1989-01-31 1996-04-04 Bard Inc C R Catheter and method for locally applied medication of the wall of a blood vessel or other body lumen.
US5087244A (en) 1989-01-31 1992-02-11 C. R. Bard, Inc. Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen
US4994033A (en) 1989-05-25 1991-02-19 Schneider (Usa) Inc. Intravascular drug delivery dilatation catheter
US5102402A (en) 1991-01-04 1992-04-07 Medtronic, Inc. Releasable coatings on balloon catheters
WO1994023787A1 (en) 1993-04-22 1994-10-27 Rammler David H Sampling balloon catheter
US7947015B2 (en) * 1999-01-25 2011-05-24 Atrium Medical Corporation Application of a therapeutic substance to a tissue location using an expandable medical device
US7572245B2 (en) * 2003-09-15 2009-08-11 Atrium Medical Corporation Application of a therapeutic substance to a tissue location using an expandable medical device
AU774553B2 (en) 1999-06-24 2004-07-01 Biocompatibles Limited Balloon expandable stent
KR20030045847A (en) 2000-10-31 2003-06-11 쿡 인코포레이티드 Coated implantable medical device
US6638246B1 (en) 2000-11-28 2003-10-28 Scimed Life Systems, Inc. Medical device for delivery of a biologically active material to a lumen
US7160317B2 (en) 2002-01-04 2007-01-09 Boston Scientific Scimed, Inc. Multiple-wing balloon catheter to reduce damage to coated expandable medical implants
DE10244847A1 (en) * 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medical device for drug delivery
US20050037048A1 (en) * 2003-08-11 2005-02-17 Young-Ho Song Medical devices containing antioxidant and therapeutic agent
EP1879632A2 (en) * 2005-04-29 2008-01-23 Atrium Medical Corporation Drug delivery coating for use with a medical device and methods of treating vascular injury
JP5075131B2 (en) * 2006-02-09 2012-11-14 ビー．ブラウン メルズンゲン アーゲー How to coat a folded balloon
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US8414909B2 (en) * 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8414910B2 (en) * 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
BRPI0823269B8 (en) * 2007-01-21 2021-06-22 Hemoteq Ag balloon catheter

Also Published As

Publication number Publication date
KR20120098624A (en) 2012-09-05
IL219165A0 (en) 2012-06-28
RU2012120089A (en) 2013-11-27
AU2010306251A1 (en) 2012-05-03
WO2011044889A1 (en) 2011-04-21
EP2461842A1 (en) 2012-06-13
DE112010004061A5 (en) 2013-02-28
US20120316496A1 (en) 2012-12-13
JP2013507204A (en) 2013-03-04
MX2012004410A (en) 2012-08-23
BR112012006925A2 (en) 2016-06-07
CA2777254A1 (en) 2011-04-21
CN102573946A (en) 2012-07-11

Similar Documents

Publication Publication Date Title
IN2012DN02419A (en)
WO2011147407A3 (en) Balloon catheter coated with an anti-restenotic active ingredient and a molecular dispersion agent that promotes transport
EP3662964A4 (en) Balloon catheter with drug coating
CR10748A (en) INDOL COMPOUND
AU2018301401A1 (en) Ready-to-use urinary catheter assembly
WO2010121840A3 (en) Shellac and paclitaxel coated catheter balloons
WO2012012772A3 (en) Drug eluting hydrogels for catheter delivery
FR2914631B1 (en) PARTICULAR NANOSTRUCTURE MATERIAL, AS PROTECTIVE COATING OF METAL SURFACES.
WO2009111300A3 (en) Gradient coating for biomedical applications
CL2009000650A1 (en) Compounds derived from amino-pyrazine, kinase-pi 3 inhibitors; pharmaceutical composition; and use for the treatment of inflammatory or allergic conditions, such as respiratory diseases, rheumatoid arthritis, ulcerative colitis, among others.
CY1119780T1 (en) PYRAZOLINODIONI PRODUCERS AS NADPH oxidation inhibitors
MX2012007209A (en) Coating agents and coated articles.
WO2012080284A3 (en) Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
WO2011156590A3 (en) Non-fouling, anti-microbial, anti-thrombogenic graft compositions
CL2011001299A1 (en) Compounds derived from benzothiazoles; pharmaceutical composition; and its use as raf inhibitors for the treatment or prophylaxis of cancer.
BRPI0814874A2 (en) combination of antimitotic agent and aurora kinase inhibitor as anticancer treatment.
EP2214765A4 (en) Manufacture of split tip catheters
WO2009064879A3 (en) Antimicrobial coatings for medical devices and methods for making and using them
WO2015153599A8 (en) Catheter structures for reducing fluoroscopy usage during endovascular procedures
BR112017010808A2 (en) prevention and treatment of microbial infections
WO2012092421A3 (en) Composition for intravascular delivery of therapeutic composition
WO2010124130A3 (en) Method for coating an elastomeric material with a layer of antitoxic material
ATE509763T1 (en) LAMINATES CONTAINING METAL OXIDE NANOPARTICLES
PH12020550222A1 (en) Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
WO2009065926A3 (en) New anticancer compounds